Role of F-18 FDG PET or PET/CT in the Evaluation of Gastric Cancer.
- Author:
Mijin YUN
1
Author Information
1. Division of Nuclear Medicine, Department of Diagnostic Radiology, Yonsei University College of Medicine, Seoul, Korea. yunmijin@yumc.yonsei.ac.kr
- Publication Type:Review
- Keywords:
gastric cancer;
F-18 FDG PET;
staging
- MeSH:
Adult;
Blood Vessels;
Endoscopy;
Humans;
Lung;
Lymph Nodes;
Mass Screening;
Neoplasm Metastasis;
Positron-Emission Tomography and Computed Tomography*;
Recurrence;
Sensitivity and Specificity;
Stomach Neoplasms*;
Unnecessary Procedures
- From:Nuclear Medicine and Molecular Imaging
2006;40(3):141-147
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PET detects only less than 50% of early gastric cancer and 62-98% of advanced gastric cancer. Therefore, mass screening programs are recommended for all adults over the age of 40 for early detection and early treatment of gastric cancer through endoscopy or various radiological tests. The most important step after being diagnosed with gastric cancer is accurate staging, which mainly evaluates tumor resectability to avoid unnecessary surgery. Important factors that affect tumor resectability are whether the tumor can be separated from adjacent organs or important blood vessels, the extent of lymph node metastasis, presence of peritoneal metastasis, or distant organ metastasis. To evaluate the extent of local tumor invasion, anatomical imaging that has superior spatial resolution is essential. There are a few studies on prognostic significance of FDG uptake with inconsistent results between them. In spite of lower sensitivities for lymph node staging, the specificities of CT and PET are very high, and the specificity for PET tends to be higher than that for CT. Limited data published so far show that PET seems less useful in the detection of lung and bone metastasis. In the evaluation of pleural or peritoneal metastasis, PET seems very specific but insensitive as well. When FDG uptake of the primary tumor is low, the distant metastasis is also known to show low FDG uptake reducing its detection. There are only a few data available in the evaluation of recurrence detection and treatment response using FDG PET.
